A survey on chronic rhinosinusitis: opinions from experts of 50 countries

Autor: Maria Luisa Bellussi, Nuray Bayar Muluk, Jacopo Cambi, Cemal Cingi, Francesco Maria Passali, Desiderio Passali
Přispěvatelé: Kırıkkale Üniversitesi
Rok vydání: 2016
Předmět:
Male
Rhinology
Mucous membrane of nose
Chronic rhinosinusitis without nasal polyps (CRSsNP)
Global Health
0302 clinical medicine
Adrenal Cortex Hormones
Surveys and Questionnaires
Chronic rhinosinusitis (CRS)
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Countries
Otorhinolaryngologist
Treatment
Adult
Aged
Anti-Bacterial Agents
Chronic Disease
Cross-Sectional Studies
Endoscopy
Female
Humans
Middle Aged
Nasal Decongestants
Nasal Mucosa
Nasal Obstruction
Nasal Polyps
Postoperative Care
Rhinitis
Sinusitis
Symptom Assessment
Therapeutic Irrigation
Nasal polyps
030212 general & internal medicine
030223 otorhinolaryngology
medicine.diagnostic_test
General Medicine
respiratory system
Nasal decongestant
Settore MED/31 - Otorinolaringoiatria
medicine.medical_specialty
Therapeutic irrigation
03 medical and health sciences
otorhinolaryngologic diseases
medicine
business.industry
medicine.disease
Dermatology
Surgery
Otorhinolaryngology
business
Zdroj: European Archives of Oto-Rhino-Laryngology. 273:2097-2109
ISSN: 1434-4726
0937-4477
Popis: Cambi, Jacopo/0000-0002-5226-2278 WOS: 000379255600019 PubMed: 26742909 Chronic rhinosinusitis (CRS) is a very prevalent inflammatory disease. Treatments vary in different countries. In the present study, we explored the approaches of physicians in 50 countries. In this cross-sectional study, a rhinosinusitis survey (RSS) was completed by Honorary and Corresponding Members (otorhinolaryngologists) of the Italian Society of Rhinology. In 79.1 % of the 50 countries, the proportion of patients suffering from CRS was 15 %. Nasal symptoms were more intense in winter (46 % of countries), and spring and autumn (22 %). The most common symptoms were nasal obstruction (86 %), postnasal drip (82 %) and headache (52 %). The most common investigative modalities in the assessment of CRS are paranasal sinus CT, fiberoptic endoscopy, and anterior rhinoscopy. CRS patients were principally treated by otorhinolaryngologists (70 %). Medical treatments included nasal corticosteroids (90 %), nasal washes (68 %), and nasal decongestants (32 %). In 88 % of countries, more than 50 %, or "about 50 %", of all patients reported subjective symptom improvement after treatment. In most of the countries, surgery was required by 20-35 % of all CRS patients. During post-surgery follow-up, nasal washes (90 %), nasal corticosteroids (76 %), and systemic antibiotics (32 %) were prescribed. In 20-40 % of all patients, CRS was associated with nasal polyps. In such patients, the medical treatment options were nasal corticosteroids (90 %), systemic corticosteroids (50 %), nasal washes (46 %), and systemic antibiotics (34 %). Treatment of CRS patients varies in different countries. Paranasal sinus CT is the most common investigative modality in the assessment of CRS, and nasal corticosteroids are the first-line treatment, in the absence or presence of nasal polyps.
Databáze: OpenAIRE
Externí odkaz: